Meet Albert Bourla, Chairman and CEO of Pfizer, the leader on the front lines of the battle against the coronavirus who delivered the first vaccine for Covid-19 to be authorized for use in the U.S., Israel, and several other countries around the world.
As a Greek Jewish immigrant to the U.S., Dr. Bourla will also share his incredible family story of surviving the Holocaust in Thessaloniki, Greece.
Under his leadership, Pfizer’s development of this vaccine has been a game-changer in the global pharmaceutical evolution. Pfizer remains a leader in the fight against this dangerous virus — including working to stay ahead of potential variants as they arise.
And learn more about UJA's efforts to help provide these critical vaccines to Holocaust survivors and other vulnerable populations as part of our ongoing Covid relief efforts.
For more information, please contact Eliana Shapiro.
Albert Bourla is the chairman and chief executive officer of Pfizer, leading Pfizer in its purpose: breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.
During his more than 25 years at Pfizer, he has built a diverse and successful career, holding several senior global positions across a range of markets and disciplines. Since joining the company in 1993, key executive roles have included Zoetis (then known as Animal Health), the Vaccines, Oncology and Consumer Healthcare business, and Pfizer Innovative Health. Prior to becoming chief executive officer, Bourla served as chief operating officer.
Curtis Lane founded MTS Health Partners in 1999 after recognizing the value that a dedicated healthcare-focused financial services firm could offer the market. MTS initially operated two businesses: investment banking advisory services and private equity investing. The two businesses are now independent, and the private equity business, which manages over $1.4 billion, has been rebranded as WindRose Health Investors. Today MTS is dedicated to investment banking through a differentiated model, with over 50 professionals who provide aligned strategic and financial advisory services. Prior to founding MTS, Curtis led the healthcare investment banking group at Bear Stearns and worked at Smith Barney.
David has held a variety of leadership positions over his decade-long involvement with UJA, most recently co-chairing the annual campaign. He’s passionate about improving the lives of fellow New Yorkers and strengthening the Jewish community.
Professionally, David is chairman and CEO of Moore Holdings, which invests in and manages a variety of private companies, and is a partner in Sonostar Ventures, LLC, an investor in start-ups and public securities.
David believes in sharing the importance and scope of UJA’s impact with all New Yorkers. As a speaker who knows how to hold an audience, David has appeared as a professional stand-up comedian. He’s also a minority owner of the Atlanta Hawks NBA team.